Danone recalls specific infant formula batches in select markets under new safety guidance

DANOYDANOY

Danone will withdraw a very limited number of specific infant formula batches from select markets to comply with updated local food safety authority guidance, while confirming through routine and additional targeted analyses that all other products meet safety regulations. Parents and healthcare professionals can contact Danone’s careline for batch-specific questions.

1. High-Protein Portfolio Drives Double-Digit Growth at DANOY

DANOY has capitalized on the surge in U.S. consumer demand for protein-rich foods, reporting double-digit year-over-year growth in its high-protein product lines, led by Oikos Greek yogurt. CoBank data show 70% of American consumers now actively seek increased protein intake, and ready-to-drink protein shake sales expanded 71% over four years to $8.1 billion. DANOY’s strategy to integrate dairy-based ingredients into baked goods, bars and beverages has generated a premium pricing opportunity of up to 12%, underpinning robust top-line momentum and bolstering margins in its Essential Dairy & Plant-Based segment.

2. Targeted Recall of Infant Formula Batches Under Revised Safety Guidance

In response to updated directives from local food safety authorities, DANOY announced a voluntary withdrawal of a limited number of specific infant formula batches produced in Ireland. The decision follows additional targeted analyses, though all routine controls confirm full regulatory compliance and product safety. The recall affects select markets only; parental and healthcare inquiries are being managed through DANOY’s dedicated careline. Management emphasizes this measure preserves consumer trust and aligns with the company’s zero-tolerance approach to food safety, safeguarding its Specialized Nutrition unit’s reputation among pediatric and clinical customers.

Sources

GRG